Neurocrine Biosciences Inc (NASDAQ:NBIX)
| 76.00 Delayed Data As of Jan 24 |  +0.90 / +1.20%Today’s Change | 71.88 Today|||52-Week Range 120.27 | -10.77% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Lippoldt Darin M Chief Legal Officer |  Sale | 2/09/2021 | 30,000 | $116.16 | $3.5M | -34.38% |
Gano Kyle W Chief Business Development Officer | Sale | 1/05/2022 | 28,266 | $85.50 | $2.4M | -8.88% |
Lloyd-smith Malcolm C Chief Regulatory Officer | Sale | 7/27/2021 | 16,709 | $93.80 | $1.6M | -19.38% |
Lippoldt Darin M Chief Legal Officer |  Buy | 2/09/2021 | 30,000 | $35.99 | $1.1M | -34.38% |
Lloyd Smith Malcolm Chief Regulatory Officer | Sale | 1/25/2021 | 8,958 | $119.95 | $1.1M | -36.47% |
Lyons Gary A Director | Sale | 6/10/2021 | 10,000 | $100.27 | $1.0M | -24.52% |
Lippoldt Darin M Chief Legal Officer | Sale | 2/09/2021 | 6,008 | $116.21 | $698.2K | -34.38% |
Lloyd Smith Malcolm Chief Regulatory Officer | Sale | 1/25/2021 | 4,601 | $119.98 | $552.0K | -36.47% |
Lyons Gary A Director | Sale | 10/07/2021 | 5,000 | $105.06 | $525.3K | -26.38% |
Grigoriadis Dimitri E Chief Research Officer | Sale | 10/07/2021 | 5,000 | $104.85 | $524.3K | -26.38% |
Page of 8